Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 07, 2026
SSPC Delivers +44% as SPCX Drops -23%: Inside the Inverse ETF Move

SSPC Delivers +44% as SPCX Drops -23%: Inside the Inverse ETF Move

Key Takeaways

  • SSPC surged approximately 44% over the past 30 days, reflecting amplified inverse exposure to a steep decline in SPCX (SpaceX) shares.
  • The underlying SpaceX stock fell roughly 23% during the same window, driven by pre-lockup-expiration anxiety, AI capital expenditure concerns, and persistent valuation compression since the June IPO.
  • SSPC is a -2x daily inverse leveraged single-stock ETF, meaning its 30-day gain roughly corresponds to twice the inverse of SPCX's decline, though daily compounding can cause divergence over multi-week holding periods.
  • The ETF's quarterly trajectory reflects broad selling pressure across the newly public aerospace and AI name, amplified by heavy short interest and an imminent wave of insider share unlocks.
  • Extreme volatility in SPCX has made SSPC one of the most actively traded inverse leveraged products in its category since launch.

SSPC Overview: The -2x Daily Inverse ETF on SpaceX

The Leverage Shares 2X Short SPCX Daily ETF (SSPC) is an actively managed inverse leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to -200% (-2x) of the daily percentage change in the share price of Space Exploration Technologies Corp. (SPCX), commonly known as SpaceX. The fund launched on June 12, 2026, and carries a net expense ratio of 0.75%.

SSPC achieves its inverse exposure through derivative instruments, primarily total return swaps on SPCX common stock, rather than by directly short-selling shares. The fund's collateral is backed by US Treasury obligations, with the First American Treasury Obligations Fund representing its largest long holding. This structure provides a defined-risk vehicle for traders seeking bearish exposure to SpaceX without the operational complexity and theoretically unlimited loss potential of traditional short-selling. Because the fund resets its leverage daily, returns over periods longer than a single trading session can deviate meaningfully from -2x the cumulative return of SPCX due to compounding effects and volatility decay. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

As a single-stock inverse leveraged product, SSPC's portfolio is concentrated entirely on one underlying name. This extreme concentration means the ETF's performance is almost exclusively a function of SPCX price direction and magnitude, making it among the most high-beta instruments available to US-listed ETF traders.

SSPC Price Performance Over the Past 30 Days and Quarter

Over the past 30 trading days, SSPC advanced from approximately $12.93 to $18.63, delivering a gain of roughly 44%. The move was not linear; the ETF experienced several sharp intra-period swings as SPCX oscillated between bouts of selling pressure and short-lived relief rallies. Daily trading volumes frequently exceeded 10 million shares, underscoring intense speculative interest on both sides of the trade.

Looking at the broader quarter—which for this recently launched fund spans roughly eight weeks since inception—SSPC has more than doubled from its earliest trading levels near $9.15 in mid-June. This trajectory mirrors the extended decline in SPCX, which fell from post-IPO highs above $225 to trade below $115, a drawdown exceeding 49%. The magnitude of SSPC's quarterly gain reflects both the severity of the SPCX selloff and the mechanical amplification inherent in a -2x daily reset structure during a sustained directional trend.

Factors Behind SSPC's 30-Day Rally

The dominant catalyst behind SSPC's 30-day rally was the accelerating decline in SPCX shares, which fell approximately 23% over the same period. Several interconnected factors pressured SpaceX stock lower.

First, investors positioned ahead of the August 6 lockup expiration, which released approximately 911.5 million insider and early-investor shares for potential sale—more than doubling the public float from roughly 639 million shares. The prospect of significantly increased share supply weighed on sentiment for weeks in advance, even though eligibility did not guarantee selling.

Second, SpaceX's first post-IPO quarterly earnings report, released August 4, revealed revenue of $7.81 billion that exceeded consensus estimates, but also disclosed quarterly capital expenditures of approximately $15.8 billion tied to AI infrastructure. The scale of AI-related spending reignited concerns about near-term profitability and cash flow, triggering a sharp post-earnings selloff that pushed SPCX to an all-time closing low of $108.27 on August 5—directly fueling a corresponding spike in SSPC.

Third, short interest in SPCX reached approximately 30–35% of the available float, making it one of the most heavily shorted stocks globally. This bearish positioning amplified downward momentum and generated substantial unrealized profits for short sellers, contributing to a self-reinforcing cycle of selling pressure that benefited SSPC holders.

Broader macro conditions also played a supporting role. A cooling of enthusiasm around high-valuation AI and technology names, combined with geopolitical uncertainty, prompted rotation away from speculative growth equities. For a name like SpaceX—priced at roughly 35–37 times projected 2026 revenue with no clear path to positive free cash flow—the shift in risk appetite proved particularly punishing.

Quarterly Drivers of SSPC Performance

SSPC's quarterly performance reflects the broader post-IPO repricing of SpaceX equity. SPCX debuted on June 12 at $135 per share and briefly surged above $225 on exceptionally high retail demand and limited float—less than 5% of total shares outstanding were initially tradable. As the initial euphoria faded and fundamental scrutiny intensified, the stock entered a persistent downtrend characterized by lower highs and lower lows.

Several structural headwinds sustained the decline. Starship's Flight 13 test, though largely successful in deploying Starlink satellites, revealed ongoing booster recovery challenges that underscored the gap between engineering milestones and commercial readiness. Concerns about Starlink subscriber growth deceleration, combined with the company's transition toward the unproven Starship platform at the expense of the reliable Falcon 9 program, added to the uncertainty surrounding future revenue trajectories.

Institutional flows reflected the deteriorating sentiment. Short sellers generated an estimated $8–20 billion in unrealized profits on SPCX positions, while funds holding direct SpaceX exposure faced redemption pressure. The staggered lockup schedule—with additional tranches scheduled through year-end—created a persistent supply overhang that discouraged dip-buying and reinforced the downtrend. SSPC, as the most direct inverse vehicle, benefited mechanically from each leg lower in SPCX.

SSPC Outlook: Key Developments to Monitor

The near-term outlook for SSPC remains tightly linked to SPCX price action, which faces a complex matrix of cross-currents. The August 6 lockup expiration passed without an immediate wave of insider selling, and SPCX rebounded more than 6% in the subsequent session. However, additional unlock tranches are scheduled for August 20, September 9, September 10, and beyond, cumulatively releasing billions of shares into the tradable float through year-end. The pace and volume of actual insider sales across these windows will be a critical determinant of SPCX price direction—and by extension, SSPC performance.

On the fundamental side, investors should monitor SpaceX's AI segment revenue trajectory relative to its capital expenditure run rate. If AI-related spending continues to outpace revenue generation, the cash-flow narrative that weighed on the stock post-earnings could persist. Conversely, evidence of improving unit economics in the Starlink connectivity business or tangible progress toward Starship reusability could stabilize SPCX and create headwinds for SSPC.

Macroeconomic factors also warrant attention. The interest rate environment, inflation trends, and broader risk appetite toward high-growth, high-valuation equities will influence the demand for inverse leveraged products. Additionally, as SPCX's float expands through successive lockup expirations, its increased weighting in benchmarks like the Nasdaq 100 could draw passive institutional flows that alter the stock's supply-demand dynamics in ways that directly affect SSPC. Traders should remember that SSPC is designed for short-term tactical use and that holding periods beyond a single day expose investors to compounding effects that can produce returns significantly different from -2x the underlying's performance.

AI Screener in Practice

In my analysis of volatile names like this, I often turn to Tickeron’s AI Screener to quickly filter for similar inverse or leveraged products and compare performance metrics across sectors. It helps surface ideas based on technical patterns and volatility signals without hours of manual work. The platform has become a regular part of how I evaluate short-term tactical opportunities in single-stock ETFs. Explore the full capabilities of the AI Screener to enhance your market research workflow.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SSPC

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


Industry description

The investment seeks daily inverse leveraged investment results, before fees and expenses, of minus two times (-200%) of the daily percentage change in the price of the common stock of SPCX. The fund is an actively managed ETF. It invests at least 80% of its net assets (plus borrowings for investment purposes) in the Underlying Security and financial instruments with economic characteristics that, in combination, provide -200% daily inverse leveraged exposure to the price of the Underlying Security, on a daily basis, consistent with the fund’s investment objective. The fund is non-diversified.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Inverse Equity
Address
United States
Phone
N/A
Web
www.ThemesETFs.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.